Skip to main content

Table 5 hTERT mRNA level in peripheral CTCs of NPC patients and control subjects

From: Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance

Group n hTERT mRNA (2-Ct) (X ± SD) t value P value
Control subjects 24 1.09 ± 0.40 8.76 <0.001
NPC patients 33 10.65 ± 4.28